检索范围:
排序: 展示方式:
Reducing biliary complications in adult-to-adult living donor liver transplantation using right lobe
YAN Lunan, WEN Tianfu, WANG Wentao, YANG Jiayin, XU Mingqing, CHEN Zheyu, WU Hong
《医学前沿(英文)》 2008年 第2卷 第2期 页码 130-133 doi: 10.1007/s11684-008-0024-z
Advances in immunopathogenesis of adult immune thrombocytopenia
null
《医学前沿(英文)》 2013年 第7卷 第4期 页码 418-424 doi: 10.1007/s11684-013-0297-8
Primary immune thrombocytopenia (ITP) is an autoimmune disorder characterized by immune-mediated accelerated platelet destruction and/or suppressed platelet production. Although the development of autoantibodies against platelet glycoproteins remains central in the pathophysiology of ITP, several abnormalities involving the cellular mechanisms of immune modulation have been identified, and the pathways behind the immune-mediated destruction of platelets have opened new avenues for the design of specific immunotherapies in an attempt to reduce the platelet destruction. This review is primarily focused on the recent literature with respect to immunopathological mechanisms in patients with ITP.
关键词: primary immune thrombocytopenia B lymphocytes T lymphocytes antigen-presenting cells cytokines
YAN Lunan, ZENG Yong, WEN Tianfu, ZHAO Jichun, WANG Wentao, YANG Jiayin, XU Mingqing, MA Yukui, CHEN Zheyu, LIU Jiangwen, WU Hong
《医学前沿(英文)》 2007年 第1卷 第2期 页码 136-141 doi: 10.1007/s11684-007-0026-2
《医学前沿(英文)》 页码 939-956 doi: 10.1007/s11684-023-0987-9
关键词: mononuclear diploid cardiomyocytes cell–cell communication cardiac fibroblast single-cell RNA sequencing cardiac regeneration
Genetic basis of adult-onset nephrotic syndrome and focal segmental glomerulosclerosis
null
《医学前沿(英文)》 2017年 第11卷 第3期 页码 333-339 doi: 10.1007/s11684-017-0564-1
Nephrotic syndrome (NS) is one of the most common glomerular diseases with signs of nephrosis, heavy proteinuria, hypoalbuminemia, and edema. Dysfunction of glomerular filtration barrier causes protein loss through the kidneys. Focal segmental glomerulosclerosis (FSGS) accounts for nearly 20% of NS among children and adults. Adult-onset FSGS/NS is often associated with low response to steroid treatment and immunosuppressive medication and poor renal survival. Several genes involved in NS and FSGS have been identified by linkage analysis and next-generation sequencing. Most of these genes encode proteins and are highly expressed in glomerular podocytes, which play crucial roles in slit-diaphragm signaling, regulation of actin cytoskeleton dynamics and maintenance of podocyte integrity, and cell–matrix interactions. In this review, we focus on the recently identified genes in the adult-onset NS and FSGS and discuss clinical significance of screening of these genes.
关键词: nephrotic syndrome focal segmental glomerulosclerosis genetic
Temporal and spatial stability of the EM/PM molecular subtypes in adult diffuse glioma
《医学前沿(英文)》 2023年 第17卷 第2期 页码 240-262 doi: 10.1007/s11684-022-0936-z
关键词: glioma progression molecular classification EM/PM subtyping intratumor heterogeneity
Emergency adult living donor right lobe liver transplantation for fulminant hepatic failure
ZHANG Feng, WANG Xuehao, LI Xiangcheng, KONG Lianbao, SUN Beicheng, LI Guoqiang, QIAN Xiaofen, CHEN Feng, WANG Ke, LU Sheng, PU Liyong, LU Ling
《医学前沿(英文)》 2007年 第1卷 第3期 页码 282-286 doi: 10.1007/s11684-007-0054-y
null
《医学前沿(英文)》 2017年 第11卷 第2期 页码 229-238 doi: 10.1007/s11684-017-0506-y
A CALLG2008 protocol was developed by the Chinese Acute Lymphoblastic Leukemia Cooperative Group for adult acute lymphoblastic leukemia (ALL). We retrospectively analyzed 153 newly diagnosed adult patients with Philadelphia chromosome (Ph)-positive ALL enrolled into imatinib (400 mg/d) plus CALLG2008 regimen between 2009 and 2015. The median age was 40 years (range, 18–68 years), with 81 (52.3%) males. The overall hematologic complete remission (CR) rate was 96.7% after induction. With a median follow-up of 24.2 months, the estimated 3-year overall survival (OS) and event-free survival (EFS) rates were 49.5% (95% confidence interval (CI): 38.5%–59.5%) and 49.2% (95% CI: 38.3%–59.2%), respectively. Fifty-eight (36 with haploidentical donor) patients underwent allogeneic hematopoietic stem cell transplantation (allo-HSCT) in first CR. Among the patients in CR1 after induction, both the 3-year OS and EFS were significantly better in the allo-HSCT group than in the without allo-HSCT group (73.2%, 95% CI: 58.3%–83.5% vs. 22.2%, 95% CI: 8.7%–39.6% and 66.5%, 95% CI: 50.7%–78.2% vs. 16.1%, 95% CI: 5.1%–32.7%, respectively). Multivariate analysis showed that allo-HSCT and achievement of major molecular response were associated with favorable OS or EFS independently. Interestingly, in the allo-HSCT cohort, the donor type (haploidentical versus matched donors) had no significant impact on EFS or OS. All these results suggested that imatinib plus CALLG2008 was an effective protocol for Ph-positive ALL. Haploidentical donors can also be a reasonable alternative expedient donor pool.
关键词: Philadelphia chromosome acute lymphoblastic leukemia imatinib CALLG2008
null
《医学前沿(英文)》 2015年 第9卷 第3期 页码 304-311 doi: 10.1007/s11684-015-0400-4
In the tyrosine kinase inhibitor (TKI) era, imatinib is the first-line therapy for patients with chronic myeloid leukemia (CML) in chronic or accelerated phase. Although second-generation TKIs (TKI2), including dasatinib and nilotinib, are appropriate treatment regimens for patients with disease that progressed to accelerated phase following imatinib therapy, allogeneic hematopoietic stem cell transplantation (allo-HSCT) is the only curative therapy. This study retrospectively analyzed the efficacy of TKI2 and HSCT for treatment of CML in accelerated phase. Ninety-three patients with CML registered in the Chinese CML alliance database from February 2001 to February 2014 were enrolled and divided into the TKI2 (n?=?33) and allo-HSCT (n?=?60) groups. In the TKI2 group, 26 and 7 patients received nilotinib and dasatinib, respectively, as initial TKI2 and 11 patients transferred to the alternative TKI2 after failure to one TKI2. In the allo-HSCT group, 22 (36.7%), 35 (58.3%), and 3 (10%) patients underwent allo-HSCT from an HLA-matched sibling donor, HLA mismatched/haploidentical donor, and unrelated donor, respectively. All patients in the HSCT group were engrafted. Overall, 69.7%, 48.5%, and 45.5% of patients presented hematological, cytogenetic, and major molecular responses, respectively, to at least one of TKI2. All 60 patients (100%) achieved CHR and cytogenetic response in the HSCT group. Patients in the TKI2 group exhibited lower 5-year overall survival rate (42.9% vs. 86.4%, P = 0.002), 5-year event-free survival rate (14.3% vs. 76.1%, P<0.001), and 5-year progression-free survival (28.6% vs. 78.1%, P<0.001) than those in the allo-HSCT group. Multivariate analysis showed that male sex and TKI2therapy were predictors of poor overall survival, whereas hemoglobin<100 g/L and TKI2 therapy were predictors of poor event-free survival and progression-free survival. These results indicated that allo-HSCT may be superior to nilotinib and dasatinib for adult patients with CML in accelerated phase.
关键词: chronic myeloid leukemia imatinib dasatinib nilotinib allogeneic hematopoietic stem cell transplantation
Ling Wang, Lining Wang, Xing Fan, Wei Tang, Jiong Hu
《医学前沿(英文)》 2021年 第15卷 第1期 页码 108-115 doi: 10.1007/s11684-019-0730-8
关键词: post-transplantation cyclophosphamide allogeneic hematopoietic stem cell transplantation lymphoid malignancies
《医学前沿(英文)》 2022年 第16卷 第4期 页码 574-583 doi: 10.1007/s11684-021-0882-1
杨朝阳, 赵文, 高钰丹, 段红梅, 郝鹏, 郝飞, 李晓光
《工程(英文)》 2021年 第7卷 第12期 页码 1713-1714 doi: 10.1016/j.eng.2021.09.009
低蛋白日粮中添加亮氨酸通过雷帕霉素靶蛋白信号通路增加成年大鼠骨骼肌重量及蛋白质合成
张博, 楚丽翠, 刘宏, 谢春元, 谯仕彦, 曾祥芳
《工程(英文)》 2017年 第3卷 第5期 页码 760-765 doi: 10.1016/J.ENG.2017.03.008
低蛋白日粮会减少动物组织中蛋白质沉积,影响骨骼肌增重。本文旨在研究低蛋白日粮中添加亮氨酸对成年大鼠骨骼肌重量和蛋白质合成的影响。试验选取36只平均体重为(214.4 ± 2.4)g的成年SD雄性大鼠,按体重相近原则平均分为3个处理,每个处理12个重复,每个重复1只大鼠。3个处理分别饲喂20%酪蛋白(20%C,CON)、10%酪蛋白 + 丙氨酸(10%C + Ala,R)以及10%酪蛋白 + 亮氨酸(10%C + Leu,RL)日粮,试验期为11 d,其中,10%C + Ala组和10%C + Leu组为等氮日粮组。试验第11天,所有大鼠大剂量一次性腹腔注射L-[ring-2H5]苯丙氨酸注射液,测定血清中的氨基酸含量、比目鱼肌和腓肠肌重量、蛋白质合成速率及mTOR信号通路相关分子的表达。结果表明,在3个处理中,RL组血清亮氨酸含量最高(P < 0.05),而异亮氨酸含量最低(P < 0.05);CON组的缬氨酸含量低于R和RL组(P < 0.05),但采食量、蛋白质合成速度和4EBP1的磷酸化高于R和RL组(P < 0.05),同时腹脂重量显著下降(P < 0.05)。与R组相比,RL组可以增加腓肠肌重量(P < 0.05),促进S6K1磷酸化(P < 0.05),增加骨骼肌蛋白质合成(P < 0.05)。本文结论如下,在成年大鼠长期采食低蛋白日粮的情况下,日粮中添加亮氨酸可以改善大鼠的生长性能,通过提高mTOR通路中S6K1磷酸化水平,促进大鼠骨骼肌蛋白质合成,抑制蛋白质降解。
Analysis of antibiotic usage for viral community-acquired pneumonia in adults
Rongmeng Jiang, Bing Han, Chang Dou, Fei Zhou, Bin Cao, Xingwang Li
《医学前沿(英文)》 2021年 第15卷 第1期 页码 139-143 doi: 10.1007/s11684-019-0736-2
工厂化循环水养殖模式放养密度对半滑舌鳎成鱼生长和肌肉营养成分的影响
王 峰,雷霁霖
《中国工程科学》 2015年 第17卷 第1期 页码 19-26
为半滑舌鳎(Cynoglossus semilaevis Günther)的集约化养成提供基础数据,在工厂化循环水养殖模式下,以处于快速生长期的大规格鱼种(0.64±0.063) kg为研究对象,设置4个密度梯度组,检测半滑舌鳎的生长及肉质相关指标,结果表明:a. 实验共进行7个月,半滑舌鳎在循环水养殖模式下的总成活率为88.01 %~93.34 %,总增重率为139.69 %~191.09 %,且随着养殖密度降低,其成活率呈下降趋势,生长速度、肥满度呈上升趋势,半滑舌鳎生长激素分泌浓度为2.522~2.862 4 μg/L,各养殖密度组的生长激素随养殖密度下降前期呈升高趋势,后期呈下降趋势;b. 各养殖密度组水分、灰分、粗蛋白、粗脂肪、氨基酸和脂肪酸含量随养殖密度变化均没有规律性变化;c. 本实验条件下,循环水养殖模式X2组即初始放养210条的处理组取得了最佳的养殖效果,月平均成活率为98.72 %,月增重为0.152 6 kg/条,经7个月的养殖,可达到23.03 kg/m3的单位产量。本实验说明半滑舌鳎在循环水养殖模式下具有很好的适应性,其生长及营养成分均处于较好的状态,同时也说明循环水养殖模式可以极大地发掘半滑舌鳎的养殖潜力,是适合半滑舌鳎集约化养殖的一种具有优势的养殖模式。
标题 作者 时间 类型 操作
Reducing biliary complications in adult-to-adult living donor liver transplantation using right lobe
YAN Lunan, WEN Tianfu, WANG Wentao, YANG Jiayin, XU Mingqing, CHEN Zheyu, WU Hong
期刊论文
Preliminary experience in adult-to-adult living donor liver transplantation in a single center in China
YAN Lunan, ZENG Yong, WEN Tianfu, ZHAO Jichun, WANG Wentao, YANG Jiayin, XU Mingqing, MA Yukui, CHEN Zheyu, LIU Jiangwen, WU Hong
期刊论文
mononuclear diploid cardiac subpopulation with minimal cell–cell communications persists in embryonic and adult
期刊论文
Emergency adult living donor right lobe liver transplantation for fulminant hepatic failure
ZHANG Feng, WANG Xuehao, LI Xiangcheng, KONG Lianbao, SUN Beicheng, LI Guoqiang, QIAN Xiaofen, CHEN Feng, WANG Ke, LU Sheng, PU Liyong, LU Ling
期刊论文
Efficacy and prognostic factors of imatinib plus CALLG2008 protocol in adult patients with newly diagnosed
null
期刊论文
Superiority of allogeneic hematopoietic stem cell transplantation to nilotinib and dasatinib for adult
null
期刊论文
with post-transplantation cyclophosphamide for allogeneic peripheral stem cell transplantation for adult
Ling Wang, Lining Wang, Xing Fan, Wei Tang, Jiong Hu
期刊论文
Lung function and air pollution exposure in adults with asthma in Beijing: a 2-year longitudinal panel study
期刊论文
Analysis of antibiotic usage for viral community-acquired pneumonia in adults
Rongmeng Jiang, Bing Han, Chang Dou, Fei Zhou, Bin Cao, Xingwang Li
期刊论文